Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to deve...

Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to a...

Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenaz...

Aurinia Announces Development Plans for Voclosporin in Europe and Japan

Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in J...

Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Medidata the leading global provider of cloud-based technology and data analytics for clinical resea...

  • Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

  • Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

  • Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

  • Aurinia Announces Development Plans for Voclosporin in Europe and Japan

  • Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Projects

NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s

Read more »
Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery

AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to deve

Read more »
Takeda Presents $1 Million Gift to the Koch Institute for Integrative Cancer Research

Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science in immuno-oncology at the Koch Institute. Over the next tw

Read more »

News

Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Medidata the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its unique technology collaboration with TESARO, Inc. was recognize

Read more »
Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases announced data supporting its product pipeli

Read more »
Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of human wounds infected or colonized with S.

Read more »

Market Reports

Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat

Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights to develop, manufacture and commercialize Abexinostat,

Read more »
Quotient Clinical Acquires Contract Drug Developer, Manufacturer QS Pharma

Quotient Clinical , the early phase drug development services provider announces that it has acquired QS Pharma, the contract development and manufacturing organisation (CDMO), based near Philadelphia

Read more »
Allergan Successfully Completes LifeCell Acquisition

Allergan plc , a leading global biopharmaceutical company announced that it has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company.     &

Read more »

Press Releases

Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

Allergan, a leading global biopharmaceutical company, announced that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, on its TARGET-NASH study.

Read more »
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration

Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan's cenicriviroc (CVC)

Read more »
Medical fair thailand 2017 reflects the bullish growth of the Medical industry in the region

This year’s edition of MEDICAL FAIR THAILAND is set to be its biggest yet with more than 700 international exhibitors expected. 17 national and country pavilions will present more than 5,000 state-o

Read more »

Featured Events

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: